Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

6.7%

1 terminated out of 15 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

67% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (7)
P 1 (1)
P 3 (1)
P 4 (1)

Trial Status

Not Yet Recruiting5
Unknown4
Recruiting3
Completed2
Terminated1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
Showing all 15 trials

Research Network

Activity Timeline